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Insomnia is the most common sleep disorder with significant psychiatric/physical comorbidi-
ties in the general population. The aim of this study is to investigate whether socioeconomic
and demographic factors are associated with gender differences in insomnia and subtypes
in Korean population.
Method
The present study used data from the nationwide, cross-sectional study on sleep among all
Koreans aged 19 to 69 years. The Insomnia Severity Index (ISI) was used to classify insom-
nia symptoms and their subtypes (cutoff value: 9.5). The Pittsburgh Sleep Quality Index
(PSQI), Goldberg Anxiety Scale (GAS) and Patient Health Questionnaire-9 (PHQ-9) were
used to measure sleep quality, anxiety and depression.
Results
A total of 2695 participants completed the survey. The overall prevalence of insomnia symp-
toms was 10.7%, including difficulty in initiating sleep (DIS) (6.8%), difficulty in maintaining
sleep (DMS) (6.5%) and early morning awakening (EMA) (6.5%), and these symptoms
were more prevalent in women than in men. Multivariate analysis showed that female gen-
der, shorter sleep time and psychiatric complications were found to be independent predic-
tors for insomnia symptoms and subtypes. After adjusting for covariates among these
factors, female gender remained a significant risk factor for insomnia symptoms and their
subtypes. As for men, low income was related to insomnia.
Conclusion
Approximately one-tenth of the sample from the Korean general population had insomnia
symptoms. The prevalence of insomnia symptom and the subtypes were more prevalent in
women than men. Gender is an independent factor for insomnia symptoms.
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Introduction
Insomnia is the most common sleep disorder in the general population. It is associated with
impaired social performance, cultural difference and daytime functioning, along with other
psychological/physical conditions [1–3]. Insomnia affects 6–18% of the general population [4–
7]. Therefore, insomnia imposes a significant personal and social burden [8]. Insomnia preva-
lence varies according to the definition of insomnia or insomnia symptom [9].
Different insomnia symptoms have been defined as subtypes of insomnia. These subtypes
include difficulty in initiating sleep (DIS), difficulty in maintaining sleep (DMS) and early
morning awakening (EMA) [9]. There are differences in the prevalence, association with
excessive daytime sleepiness and psychiatric comorbidities among these subtypes [10].
Gender, age, socioeconomic status and psychiatric comorbidities are known to be signifi-
cant factors for insomnia prevalence [9]. The elderly population has an increased insomnia
prevalence compared to the young or middle age population in almost all epidemiological
studies [11–13]. Insomnia prevalence is stable from 15 to 44 years of age and increases over 45
years [9]. Insomnia prevalence is typically higher among individuals with lower incomes and
lower education levels [14]. However, some studies have reported contradictory results [15,
16]. The association between insomnia and psychiatric disorders has been repeatedly demon-
strated. Approximately 90% and 80% of individuals with anxiety and depression had insomnia
symptoms in cross-sectional studies, respectively [17, 18]. Longitudinal studies confirmed the
close association of anxiety and depression with insomnia [16, 19].
Short sleep time and poor sleep quality are significant factors for insomnia. A survey in six
European countries showed that a significant proportion of individuals with insomnia had
short sleep times either voluntarily or non-voluntarily [20]. The authors classified sleep depri-
vation as a subtype of insomnia. Poor sleep quality is also common among individuals with
insomnia [21].
Female gender has been recognized as a significant factor for insomnia. Epidemiological
studies have consistently shown a higher prevalence of insomnia symptoms among women
compared to men [22–24]. The difference in insomnia prevalence between women and men
increases with age [9]. In addition to insomnia or insomnia symptoms, women report more
frequent dissatisfaction with sleep and the daytime consequences of insomnia [4, 22, 24].
Nevertheless, information regarding gender differences in insomnia subtypes is currently
limited. In addition, gender differences in insomnia symptoms adjusting for significant covari-
ates have rarely been reported. The purpose of this study is to investigate gender differences in
insomnia symptoms and their subtypes regarding covariates using population data in South
Korea.
Methods
Study population and survey process
The present study population was collected from cross-sectional surveys. In brief, it was a
nationwide, cross-sectional study on sleep among Koreans aged 19 to 69 years. We used a two-
stage clustered random sampling method proportional to the population and socioeconomic
distribution for all Korean territories. The study protocol was approved by the institutional
review board/ethics committee of Hallym University Sacred Heart Hospital in Korea(Approval
No. 2011-I077), conducted according to the principles expressed in the Declaration of Hel-
sinki.; Participants provided their written informed consent to participate in this study.
Trained interviewers conducted structured interviews using a questionnaire to assess sleep
time, sleepiness, anxiety and depression using a face-to-face interview. The interview included
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questions on sleep status. To minimize potential interest bias, we informed candidates that the
topic of the survey was social health issues rather than sleep issues. All interviewers were
employed by Gallup Korea and had previous social survey interviewing experience.
Assessment for sleep time
We asked all participants to report their usual sleep time in terms of hours and minutes, sepa-
rately for workdays and free days, during the past month. The average sleep time was a
weighted mean of the sleep time on workdays and free days, calculated as ([workday sleep time
x 5] + [free day sleep time x 2))/7. Short sleep time was defined as an average sleep time of
<6 h [25].
Assessment for insomnia symptom and poor sleep quality
The Insomnia Severity Index (ISI) was used to classify insomnia symptoms. The ISI is a self-
reporting, brief screening measure of insomnia that contains questions corresponding in part
to the diagnostic criteria of insomnia [26]. The ISI comprises seven items concerning the sever-
ity of sleep-onset difficulty, sleep-maintaining difficulty, early awakening and satisfaction with
sleep patterns. Each item was rated on a 0–4 scale [27]. The ISI was previously validated with
good sensitivity and specificity and showed a 9.5 cut-off score for discriminating patients with
“insomnia symptoms” in the population-based sample [28]. Among those who satisfy this defi-
nition (ISI score� 10), we further classified the subtypes of insomnia symptoms as difficulty in
initiating sleep (DIS), difficulty in maintaining sleep (DMS) and early morning awakening
(EMA) if a participant responded with� 2 on the scale (intermediate or higher) for those
items [20]. The Pittsburgh Sleep Quality Index (PSQI) was used to measure sleep quality. If a
participant’s PSQI score was 6 or higher, she/he was classified as having poor sleep quality [29].
Anxiety and depression assessment
We used the Goldberg Anxiety Scale (GAS) to diagnose anxiety among participants. The GAS
questionnaire was composed of nine items: four screening items and five supplementary
items. Anxiety was diagnosed when there were positive answers to two or more screening
items and five or more of all scale items [30]. The Korean version of the scale has a sensitivity
of 82.0% and specificity of 94.4% for diagnosing anxiety [31].
The Patient Health Questionnaire-9 (PHQ-9) was used to diagnose depression [32]. It is
composed of nine items each scored 0 to 3. Participants who scored 10 or higher on this mea-
sure were considered to have depression. The Korean PHQ-9 has a sensitivity of 81.8% and
specificity of 89.9% [33].
Statistical analysis
The Kolmogorov–Smirnov test was used to confirm the normality of the distribution. The Stu-
dent’s t-test was used to compare continuous variables after the normality of the sample was
confirmed. Post hoc analyses were performed using Tukey’s method. Categorical variables
were compared using the Chi-square test. The significance level was set at p< 0.05 for all
analyses.
We calculated the odds ratios (ORs) with 95% confidence intervals (CIs) for the occurrence
of insomnia symptoms and their subtypes through univariable and multivariable logistic
regression analyses. In univariable analyses, we modelled the ORs for insomnia symptoms
without adjusting for covariates. In multivariable analyses, we used four models. In Model 1,
adjustment was conducted for sociodemographic variables (age, gender, size of residential area
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and educational level) and short sleep time. Model 2 incorporated anxiety (GAS score) with
Model 1. Model 3 included depression (PHQ-9 score� 10) with Model 1. The final model,
Model 4, incorporated poor sleep quality (PSQI score� 6), anxiety and depression with
Model 1. Statistical analyses were performed using the Statistical Package for Social Sciences
23.0 (IBM, Armonk, NY, USA).
Results
Survey
The interviewers approached 7,430 individuals and 3114 of them agreed to take the survey.
After 352 individuals suspended the interview, 2695 participants completed the survey (coop-
eration rate of 36.2%; Fig 1). The distributions of age, gender, size of residential area and edu-
cational level were not significantly different from those of the general population of Korea.
(Table 1).
Prevalence of insomnia and poor sleep quality
Of the 2695 participants, 290 (10.7%) were classified as having insomnia symptoms according
to the ISI score. Seven-hundred and fifteen (26.5%) participants who reported PSQI scores
higher than 5 were classified as having poor sleep quality. 182 (6.8% of all participants) were
accompanied by DIS, 175 (6.5%) with DMS and 176 (6.5%) with EMA (Fig 2).
Demographic characteristics, psychiatric comorbidities and short sleep
time according to the presence of insomnia symptom
The mean age of participants with insomnia symptoms did not significantly differ from partic-
ipants without insomnia symptoms (43.8 ± 14.2 vs. 42.9 ± 13.7, p = 0.823). The proportion of
Fig 1. Flow chart depicting the participation of subjects in the Korean headache-sleep study.
https://doi.org/10.1371/journal.pone.0227190.g001
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women was higher among participants with insomnia symptoms than those without insomnia
symptoms (59.6% vs. 49.1%, p< 0.001). The prevalence of anxiety and depression was signifi-
cantly higher among participants with insomnia symptoms than in those without (40.3% vs.
6.3%, p< 0.001 for anxiety and 25.9% vs. 1.7%, p< 0.001 for depression). The average sleep
time of all participants was 7.4 ± 1.3 h.
Two-hundred and seventy-seven (10.3%) participants were classified as having short sleep
time. The average sleep time of participants with insomnia symptoms was significantly shorter
than that of participants without insomnia symptoms (6.7 ± 1.5 h vs. 7.4 ± 1.2 h, p< 0.001).
The prevalence of short sleep time (< 6 hours of average sleep time) was higher among partici-
pants with insomnia symptoms (35.5% vs. 15.2%, p< 0.001; Table 2).
Prevalence of insomnia symptoms in women and men
A higher percentage of women reported insomnia symptoms compared to men (12.8% vs.
8.7%, p = 0.001). The mean ISI score was significantly higher in women compared to men





P Poor sleep quality N,
% (95% CI)








Men 1,345 (49.3) 17,584,365 (50.6) 0.854a 334, 24.8 (22.5–27.1) 0.046 117, 8.7 (7.2–10.2) 0.001 141, 10.5
(8.8–12.1)
0.727 7.3 + 1.2 0.109






19–29 542 (20.5) 7,717,947 (22.2) 0.917a 153, 28.3 (24.4–32.0) 0.028 59, 10.9 (9.2–12.6) 0.426 45, 8.3 (6.0–
10.6)
0.002 7.6 + 1.3 <0.001
30–39 604 (21.9) 8,349,487 (24.0) 136, 22.5 (19.2–25.9) 53, 8.8 (7.3–10.3) 42, 7.0 (4.9–
9.0)
7.5 + 1.1
40–49 611 (23.1) 8,613,110 (24.8) 167, 27.3 (23.8–30.1) 66, 10.8 (9.1–12.5) 73, 11.9 (9.4–
14.5)
7.1 + 1.2
















0.670 7.3 + 1.2 0.471
Medium-to-small
city











393 (14.9) 6,608,716 (19.0) 0.752a 110, 28.0 (23.5–32.4) 0.917 62, 15.8 (13.8–
17.7)
0.006 47, 12.0 (8.7–
15.2)
0.514 7.2 + 1.4 0.012
High school 1,208 (44.5) 15,234,829 (43.8) 317, 26.2 (24.0–28.7) 116, 9.6 (8.0–11.2) 127, 10.5
(8.8–12.3)
7.2 + 1.3





Not responded 26 (9.6) 7, 26.9 (8.7–45.2) 3, 1.0 (0.9–1.3) 3, 11.5 (0.0–
24.7)
7.4 +1.2





aComparison of gender, age group, size of residential area, and educational level distributions between the sample in the present study and the total population of Korea
Abbreviations: CI = confidence interval
https://doi.org/10.1371/journal.pone.0227190.t001
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(4.2 ± 4.9 vs. 3.3 ± 4.2, p< 0.001). All subtypes of insomnia symptoms including DIS (8.3% vs.
5.1%, p< 0.001), DMS (8.5% vs. 4.4%, p< 0.001) and EMA (8.0% vs. 5.0%, p = 0.001) were
more prevalent in women than men (Fig 2).
Insomnia severity of women and men among participants with insomnia
Among 290 participants with insomnia symptoms, the total ISI score was not significantly dif-
ferent between women and men (14.6 ± 4.4 vs. 14.0 ± 4.3, p = 0.199). The prevalence of DIS
(37.6% vs. 33.3%, p = 0.460), DMS (40.5% vs. 32.5%, p = 0.168) and EMA (36.4% vs. 29.9%,
p = 0.251) did not significantly differ between women and men.
Factors associated with insomnia symptoms in women and men
When comparing participants with insomnia symptoms to participants without insomnia
symptoms, age, size of residential area and education level did not significantly affect the prev-
alence of insomnia. In contrast, female gender (OR = 1.3, 95% CI = 1.0–1.78), short sleep time
(OR = 2.6, 95% CI = 1.9–3.5), anxiety (OR = 6.0, 95% CI = 4.3–8.3) and depression (OR = 9.6,
95% CI = 6.0–15.3) were found to be independent predictors of insomnia symptoms in multi-
ple regression analysis (Table 3).
For DIS, female gender (OR = 1.4, 95% CI = 1.0–2.0), short sleep time (OR = 3.1, 95%
CI = 2.1–4.4), anxiety (OR = 5.0, 95% CI = 3.4–7.3) and depression (OR = 9.6, 95% CI = 6.0–
15.5) were found to be independent predictors (S1 Table).
Fig 2. Prevalence of insomnia symptoms in men and women with different age groups. p was calculated by χ2 test. Abbreviations:
IS = Insomnia Symptoms, DIS = Difficulty in Initiating Sleep; DMS = Difficulty in Maintaining Sleep; EMA = Early Morning
Awakening.
https://doi.org/10.1371/journal.pone.0227190.g002
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Table 2. Distribution of demographic, social and lifestyle factors according to the presence of insomnia symptoms.
Subjects with IS N = 290 Subjects without IS N = 2405 P-value
Demographics
Mean age ± SD (years) 43.76±14.20 42.88±13.70 0.366
Women, N (%) 173 (59.6) 1182 (49.1) 0.001
Education level
Middle school or less 62 331 0.006
High school 116 1092
College or more 109 959
Not responded 3 23
Residential area
Large city 136 1112 0.943
Medium-to-small city 125 1061
Rural area 29 232
Smoking, N (%) 78 (26.9) 666 (27.7) 0.486
Alcohol, N (%) 185 (63.8) 1597 (66.4) 0.313
ISI score, ± SD 14.37±4.39 2.47±2.50
Anxiety, N (%) 117 (40.3) 151 (6.3) <0.001
Depression, N (%) 75 (25.9) 41 (1.7) <0.001
BMI, ± SD (kg/cm^2) 23.09± 3.30 22.94± 2.97 0.031
Average sleep duration, ± SD, N (short sleep duration) 6.68± 1.54 (103) 7.36± 1.17 (366) <0.001
Poor sleep quality, N (%) 221 (76) 494 (20.5) <0.001
p was calculated by χ2 test or student’s t test.
Abbreviations: IS–Insomnia symptoms
https://doi.org/10.1371/journal.pone.0227190.t002
Table 3. Univariable and multivariable regression analysis for insomnia symptoms.
Univariable ORs Multivariable analysis ORs
Model 1 Model 2 Model 3 Model4
OR (95%Ci) p-value OR (95%Ci) p-value OR (95%Ci) p-value OR (95%Ci) p-value OR (95%Ci) p-value
Sex (Women) 1.543 (1.204–1.977) 0.001 1.513 (1.172–1.953) 0.001 1.401 (1.068–1.839) 0.015 1.388 (1.057–1.824) 0.018 1.327 (1.000–1.760) 0.05
Age (40 years or
older)
1.199 (0.934–1.539) 0.155 0.928 (0.702–1.226) 0.599 0.938 (0.698–1.261) 0.673 1.028 (0.762–1.387) 0.856 0.999 (0.734–1.361) 0.997
Size of residential
area (Large city)
1.027 (0.804–1.311) 0.831 1.037 (0.807–1.332) 0.779 1.004 (0.768–1.312) 0.977 1.010 (0.771–1.321) 0.944 0.990 (0.749–1.308) 0.943
Education (Middle
school or less)
1.707 (1.260–2.314) 0.001 1.552 (1.105–2.180) 0.011 1.427 (0.993–2.051) 0.055 1.556 (1.083–2.235) 0.017 1.473 (1.009–2.150) 0.045
Sleep duration (6
hours or shorter)
3.069 (2.354–4.000) <0.001 3.081 (2.348–4.042) <0.001 2.738 (2.039–3.675) <0.001 2.780 (2.069–3.736) <0.001 2.604 (1.913–3.544) <0.001
Anxiety 10.095 (7.579–13.447) <0.001 9.284 (6.910–12.473) <0.001 6.014 (4.344–8.325) <0.001
Depression 20.113 (13.409–30.170) <0.001 18.626 (12.243–28.336) <0.001 9.588 (6.026–15.257) <0.001
In Model 1, adjustment was conducted for sociodemographic variables (age, sex, size of residential area and educational level) and short sleep time. Model 2
incorporated anxiety (GAS score) with Model 1. Model 3 included depression (PHQ-9 score� 10) with Model 1. The final model, Model 4, incorporated poor sleep
quality (PSQI score� 6), anxiety and depression with Model 1. Subject with missing data was excluded from the analysis.
p was calculated by the univariable / multiple logistic regression analysis.
Abbreviations: OR = odds ratio, CI = confidence interval.
https://doi.org/10.1371/journal.pone.0227190.t003
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In univariable analysis, age was a significant predictor of DIS (1.5, 95% CI = 1.1–2.1) and
DMS (OR = 1.5, 95% CI = 1.1–2.0). However, age lost significance for DIS (p = 0.235) and
DMS (p = 0.219) in multiple regression analysis. Female gender (OR = 1.8, 95% CI = 1.2–2.6),
short sleep time (OR = 2.5, 95% CI = 1.7–3.7), anxiety (OR = 5.2, 95% CI = 3.6–7.7) and
depression (OR = 8.6, 95% CI = 5.3–13.9) were significant predictors of DMS in multiple
regression analysis (S2 Table).
In multiple regression analysis for EMA, female gender (OR = 1.4, 95% CI = 1.0–2.0), age
(OR = 1.8, 95% CI = 1.2–2.6), educational level (OR = 1.6, 95% CI = 1.1–2.5), short sleep time
(OR = 3.7, 95% CI = 2.6–5.3), anxiety (OR = 5.1, 95% CI = 3.4–7.6) and depression (OR = 5.7,
95% CI = 3.4–9.4) were independent predictors (S3 Table).
Women showed similar result aspects. In multiple regression analysis for insomnia symp-
toms, short sleep time (OR = 2.2, 95% CI = 1.4–3.3), anxiety (OR = 6.1, 95% CI = 4.0–9.3), and
depression (OR = 6.9, 95% CI = 3.8–12.3) were significant predictors. Those factors also had
significance for insomnia symptoms, DIS, DMS and EMA in multiple regression analysis for
both genders. Additionally, relatively low monthly income was a significant risk factor for men
in insomnia symptoms and their subtypes (Table 4), while no socio-economic risk factor was
related to female insomnia. (S4 Table).
Discussion
The main findings of the present study were as follows: 1) The prevalence of insomnia symp-
toms in a Korean general population-based sample was 10.7% and 2) The prevalence of insom-
nia symptoms was significantly higher in women than men. Among the subtypes of insomnia
symptoms, there was a higher prevalence of DIS, DMA and EMA in women than in men and
3) Female gender was a significant factor for insomnia symptoms even after adjusting for
covariates including sociodemographic variables, short sleep time, anxiety and depression.
General insomnia prevalence was similar with that reported in previous study [34]. Gender
differences in insomnia disorder or insomnia symptoms have also been demonstrated in epi-
demiological studies. A meta-analysis combining data from 29 studies reported that women
were at a 41% greater risk for having insomnia than men in adult populations [22]. Our results
are in agreement with the previous findings that women had more insomnia symptoms than
men.
Table 4. Univariable and multivariable regression analysis for insomnia symptoms and insomnia subtypes in men.
Multivariable analysis ORs
IS DIS DMS EMA
OR (95%Ci) p-value OR (95%Ci) p-value OR (95%Ci) p-value OR (95%Ci) p-value
Age (40 years or older) 0.772 (0.479–1.244) 0.287 1.204 (0.653–2.222) 0.552 1.220 (0.630–2.362) 0.555 1.469 (0.767–2.816) 0.246
Size of residential area (Large city) 1.433 (0.919–2.235) 0.113 1.420 (0.809–2.493) 0.222 1.104 (0.607–2.010) 0.745 0.932 (0.523–1.659) 0.810
Education (Middle school or less) 0.869 (0.411–1.836) 0.713 0.598 (0.236–1.517) 0.279 0.865 (0.362–2.071) 0.745 0.810 (0.345–1.900) 0.628
Sleep duration (6 hours or shorter) 3.489 (2.177–5.591) <0.001 3.664 (2.055–6.533) <0.001 3.247 (1.756–6.006) <0.001 4.855 (2.724–8.654) <0.001
Anxiety 6.031 (3.517–10.341) <0.001 6.059 (3.215–11.419) <0.001 9.307 (4.113–21.061) <0.001 6.849 (3.630–12.922) <0.001
Depression 18.158 (8.267–39.882) <0.001 12.766 (5.677–28.711) <0.001 5.578 (2.855–10.900) <0.001 7.614 (3.306–17.536) <0.001
Monthly income (<,2000 dollar) 2.030 (1.130–3.645) 0.018 2.006 (0.988–4.074) 0.054 2.776 (1.363–5.653) 0.005 2.477 (1.231–4.984) 0.011
Occupation (unemployed) 1.174 (0.644–2.141) 0.600 1.487 (0.708–3.123) 0.295 0.798 (0.338–1.881) 0.606 0.834 (0.360–1.928) 0.671
Subject with missing data was excluded from the analysis.
p was calculated by the univariable / multiple logistic regression analysis.
Abbreviations: OR = odds ratio, CI = confidence interval, IS = Insomnia Symptoms, DIS = Difficulty in Initiating Sleep, DMS = Difficulty in Maintaining Sleep,
EMA = Early Morning Awakening
https://doi.org/10.1371/journal.pone.0227190.t004
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What are possible mechanisms for higher insomnia prevalence in women? One possible
explanation is roles of sex steroids. The major gonadal sex steroids are estrogen and progester-
one in women and testosterone in men [35]. Sleep complaints typically co-occur in women
with the fluctuation of ovarian steroids such as puberty, pregnancy, the menstrual cycle and
the menopausal period [36–38]. Estrogen replacement therapy improves sleep disturbances in
menopausal women [37]. In men, androgen deprivation therapy worsens insomnia in prostate
cancer patients [38, 39]. On the contrary, high-dose testosterone replacement was associated
with a reduction of sleep efficacy and total sleep time [40]. In summary, low or fluctuating lev-
els of estrogen was consistently associated with increase occurrence of sleep disturbances
including insomnia in women. Nevertheless, role of testosterone level on sleep in men is cur-
rently uncertain owing to inconsistent results.
Another possible explanation is role of biological gender. Androgen and estrogen affect dif-
ferently on sleep between women and men. Gonadectomized female and male rats showed no
significant difference in NREM and REM sleep amount. However, estradiol replacement sig-
nificantly reduces NREM and REM sleep time in dark phase in female rats. In contrast, NREM
and REM sleep architecture did not change by estradiol treatment in male rats [41]. Therefore,
gender difference may be owing to biological gender rather than sex steroids.
The higher prevalence of mood symptoms in women could be a reason for gender differ-
ence. Both anxiety and depression are closely associated with sleep disturbances, including
insomnia. Epidemiological studies have consistently reported a close association of insomnia
with anxiety and depression. A meta-analysis including 21 longitudinal epidemiological stud-
ies showed an odds ratio for insomnia to predict depression of 2.60 (confidence interval: 1.98–
3.42) [42]. Women preponderance of anxiety and depression has been persistently noted [43,
44]. Therefore, a higher prevalence of anxiety and depression in women may account for the
higher prevalence of insomnia in women than men. Nevertheless, insomnia prevalence was
significantly higher in women than men even after adjusting for anxiety and depression in the
present study (Table 3). Therefore, the higher prevalence of insomnia in women could not be
solely explained by the higher prevalence of anxiety and depression in women.
Differences in pain and somatic perception can also explain gender differences in insomnia
symptoms. Pain and somatic symptoms are generally more prevalent in women [22, 45]. In
particular, pain, insomnia, and somatic symptoms showed significant differences in adults
rather than in adolescents before puberty. [46] These differences might speculate the relation-
ship between sex and insomnia symptoms.
The present study showed that all subtypes of insomnia symptoms including DIS, DMS
and EMA were more common in women than men. The significant differences in prevalence
between women and men persisted even after adjusting for covariates including sociodemo-
graphic variables, short sleep time, anxiety and depression. Gender differences in the subtypes
of insomnia have been demonstrated in epidemiological studies. Janson et al. reported that
female gender was positively related to DMS in a European study [47]. An interview-based
study showed a clear correlation between female gender and insomnia symptoms as well as the
DMS-IV inclusion criteria [23]. Another study showed that 11.9% (14.0% of women vs. 9.3%
of men) of the Hong Kong Chinese adult population complained of insomnia in the preceding
month. Insomnia symptoms including DIS, DMS and EMA, more prominently appeared in
women than in men. Gender (as women) was a specific risk factor despite common risk factors
for insomnia in both genders [24].
The prevalence of EMA only showed significance in older individuals after including anxi-
ety and depression in the adjustment (S3 Table). Still, we found a tendency that prevalence of
insomnia symptoms increased with age. In this study, inclusion criteria for participants maxi-
mally limited to 69 years, and the size of the sample was small. These are possible explanations
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for the absence of statistical significance. (Table 1). Gender differences in insomnia prevalence
were apparent in the elderly in epidemiological studies. In elderly populations, the risk of
insomnia in women was almost doubled compared to that of men. Elderly (>65 years) women
had a 73% greater risk of insomnia compared to elderly men [22]. In contrast, the predisposi-
tion for insomnia in women did not appear before puberty. These findings suggest a possible
role of hormonal changes in the differences in insomnia between women and men [48, 49].
Also, we failed to report lower education levels as independent risk factor for insomnia and all
subtypes. The statistical significance of low monthly income in men alone offered weak
explanatory power, due to disputes in recent studies [9].
Despite of the low response rate (36.3%), we can speculate the general status of the Korean
population through our data: 1) there were no significant differences in the distribution of age,
gender, size of residential area, and educational level between survey participants and the
Korean general population. 2) The prevalence of insomnia symptoms, anxiety, depression,
and short sleep duration in this sample were similar to that of previous studies [4].
The present study has some limitations. First, this study did not use any objective measure-
ment of sleep or sleep disorders such as polysomnography or actigraphy. Nevertheless, we
evaluated insomnia symptoms, sleep habits and sleep quality using validated questionnaires
via face-to-face interviews. Second, we did not evaluate the use of antidepressants, anxiolytics,
hypnotics or caffeine. Antidepressants, anxiolytics or hypnotics may have a positive effect on
sleep time and caffeine may negatively affect sleep time. Also, we could not measure sleep-rele-
vant-treatments such as sleep-education, relaxation training or cognitive behavioral therapy
for insomnia (CBTI). Third, although the present study was a large population-based study,
some subgroup analyses might not have statistical significance due to the limited sample size
and low response rate. In other words, the lack of significant findings in subgroup analyses
could be due to the small subgroup sample size.
The present study has several strengths. First, the present study included a large sample size
across the Korean general population. The distribution of age, gender, size of residential area
and educational level of our sample was similar to the Korean population. Second, the present
study assessed potential covariates of insomnia symptoms such as sociodemographic variables,
poor sleep quality, short sleep time, anxiety and depression, which are related to insomnia
symptoms. Third, we investigated gender differences in the subtypes of insomnia symptoms
including DIS, DMS and EMA in addition to overall insomnia symptoms. Further, we ana-
lyzed the factors affecting insomnia subtypes.
Conclusions
Approximately one-tenth of the Korean general population sample had insomnia symptoms.
The prevalence of insomnia symptoms was higher in women than men. Among the subtypes
of insomnia symptoms, DIS, DMS and EMA were more prevalent in women than in men. The
predisposition of insomnia symptoms in women was prominent even after adjusting for covar-
iates including anxiety and depression.
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The final model, Model 4, incorporated poor sleep quality (PSQI score� 6), anxiety and
depression with Model 1. Subject with missing data was excluded from the analysis. p was cal-
culated by the univariable / multiple logistic regression analysis. Abbreviations: OR = odds
ratio, CI = confidence interval.
(DOCX)
S4 Table. Univariable and multivariable regression analysis for insomnia symptoms and
insomnia subtypes in women. Subject with missing data was excluded from the analysis.
p was calculated by the univariable / multiple logistic regression analysis. Abbreviations:
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